Prostate stem cells, hormones, and development

Stem Cells and Prostate Cancer

Volumn , Issue , 2013, Pages 1-20

  Prins, Gail S ^a   Hu, Wen Yang ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84949178438     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-6498-3_1     Document Type: Chapter

References (97)

1. Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER, Yasuda H, Smyth GK, Martin TJ, Lindeman GJ et al (2010) Control of mammary stem cell function by steroid hormone signalling. Nature 465:798-802
2. Berry PA, Maitland NJ, Collins AT (2008) Androgen receptor signalling in prostate: effects of stromal factors on normal and cancer stem cells. Mol Cell Endocrinol 288:30-37
3. Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, Kim M, Desai N, Young P, Norton CR, Gridley T, Cardiff RD, Cunha GR et al (1999) Roles for Nkx3.1 in prostate development and cancer. Gen Devel 13:966-977
4. Bhatt RI, Brown MD, Hart CA, Gilmore P, Ramani VA, George NJ, Clarke NW (2003) Novel method for the isolation and characterisation of the putative prostatic stem cell. Cytometry A 54:89-99
5. Brown MD, Gilmore PE, Hart CA, Samuel JD, Ramani VA, George NJ, Clarke NW (2007) Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations. Prostate 67:1384-1396
6. Chan KW, Yu KL, Rivier J, Chow BK (1998) Identification and characterization of a receptor from goldfish specific for a teleost growth hormone-releasing hormone-like peptide. Neuroendocrinology 68:44-56
7. Chan QK, Lam HM, Ng CF, Lee AY, Chan ES, Ng HK, Ho SM, Lau KM (2010) Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest. Cell Death Differ 17:1511-1523
8. Cocciadiferro L, Miceli V, Kang KS, Polito LM, Trosko JE, Carruba G (2009) Profiling cancer stem cells in androgen-responsive and refractory human prostate tumor cell lines. Ann NY Acad Sci 1155:257-262
9. Collins AT, Habib FK, Maitland NJ, Neal DE (2001) Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J Cell Sci 114:3865-3872
10. Cunha GR (1973) The role of androgens in the epithelio-mesenchymal interactions involved in prostatic morphogenesis in embryonic mice. Anat Rec 175:87-96
11. Cunha GR (1976) Epithelial-stromal interactions in development of the urogenital tract. Int Rev Cytol 47:137-194
12. Cunha GR (1984) Prostatic epithelial morphogenesis, growth, and secretory cytodifferentiation are elicited via trophic infl uences from mesenchyme. In: Progress in cancer research and therapy (ed. F. Bresciani), 31:121-128. New York: Raven Press
13. Cunha G, Fujii H, Neubauer B, Shannon J, Sawyer L, Reese B (1983) Epithelial-mesenchymal interactions in prostatic development. I. Morphological observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder. J Cell Biol 96:1662-1670
14. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y (1987) The endocrinology and developmental biology of the prostate. Endocr Rev 8:338-363
15. Dagvadorj A, Collins S, Jomain JB, Abdulghani J, Karras J, Zellweger T, Li H, Nurmi M, Alanen K, Mirtti T et al (2007) Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway. Endocrinology 148:3089-3101
16. Ding XW, Wu JH, Jiang CP (2010) ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sci 86:631-637
17. Donjacour AA, Cunha GR (1993) Assessment of prostatic protein secretion in tissue recombinants made of urogenital sinus mesenchyme and urothelium from normal or androgen-insensitive mice. Endocrinology 132:2342-2350
18. Donjacour AA, Cunha GR (1995) Induction of prostatic morphology and secretion in urothelium by seminal vesicle mesenchyme. Development 121:2199-2207
19. Garraway LA, Lin D, Signoretti S, Waltregny D, Dilks J, Bhattacharya N, Loda M (2003) Intermediate basal cells of the prostate: in vitro and in vivo characterization. Prostate 55:206-218
20. Garraway IP, Sun W, Tran CP, Perner S, Zhang B, Goldstein AS, Hahm SA, Haider M, Head CS, Reiter RE et al (2010) Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate 70:491-501
21. Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP, Witte ON (2008) Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci USA 105:20882-20887
22. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON (2010a) Identification of a cell of origin for human prostate cancer. Science 329:568-571
23. Goldstein AS, Stoyanova T, Witte ON (2010b) Primitive origins of prostate cancer: In vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells. Mol Oncol 4:385-396
24. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC (1996) Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183:1797-1806
25. Goto K, Salm SN, Coetzee S, Xiong X, Burger PE, Shapiro E, Lepor H, Moscatelli D, Wilson EL (2006) Proximal prostatic stem cells are programmed to regenerate a proximal-distal ductal axis. Stem Cells 24:1859-1868
26. Gu G, Yuan J, Wills M, Kasper S (2007) Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 67:4708-4715
27. Guo C, Liu H, Zhang BH, Cadaneanu RM, Mayle AM, Garraway IP (2012) Epcam, CD44, and CD49f distinguish sphere-forming human prostate basal cells from a subpopulation with predominant tubule initiation capability. PLoS One 7:e34219
28. Hayashi N, Sugimura Y, Kawamura J, Donjacour AA, Cunha GR (1991) Morphological and functional heterogeneity in the rat prostatic gland. Biol Reprod 45:308-321
29. Hayward S, Cunha G, Dahiya R (1996) Normal development and carcinogenesis of the prostate; a unifying hypothesis. Ann NY Acad Sci 784:50-62
30. Hu WY, Shi GB, Lam HM, Hu DP, Ho SM, Madueke IC, Kajdacsy-Balla A, Prins GS (2011) Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells. Endocrinology 152:2150-2163
31. Hu WY, Shi GB, Hu DP, Nelles JL, Prins GS (2012) Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk. Mol Cell Endocrinol 354:63-73
32. Huang L, Pu Y, Hu WY, Birch L, Luccio-Camelo D, Yamaguchi T, Prins GS (2009) The role of Wnt5a in prostate gland development. Dev Biol 328(2):188-199
33. Hudson DL (2004) Epithelial stem cells in human prostate growth and disease. Prostate Cancer Prostatic Dis 7:188-194
34. Hudson DL, O?Hare M, Watt FM, Masters JR (2000) Proliferative heterogeneity in the human prostate: evidence for epithelial stem cells. Lab Invest 80:1243-1250
35. Huss JJ, Lai L, Barrios RJ, Hirschi KK, Greenberg NM (2004) Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer. Prostate 61:142-152
36. Isaacs JT (2008) Prostate stem cells and benign prostatic hyperplasia. Prostate 68:1025-1034
37. Isaacs JT, Coffey DS (1989) Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl 2:33-50
38. Isaacs JT, Barrack ER, Isaacs WB, Coffey DS (1981) The relationship of cellular structure and function: the matrix system. Prog Clin Biol Res 75A:1-24
39. Joshi PA, Jackson HW, Beristain AG, Di Grappa MA, Mote PA, Clarke CL, Stingl J, Waterhouse PD, Khokha R (2010) Progesterone induces adult mammary stem cell expansion. Nature 465: 803-807
40. Kasper S (2007) Characterizing the prostate stem cell. J Urol 178:375
41. Kasper S (2008) Exploring the origins of the normal prostate and prostate cancer stem cell. Stem Cell Rev 4:193-201
42. Kasper S (2009) Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens. Urol Oncol 27:301-303
43. Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, Witte ON (2010) Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc Natl Acad Sci USA 107:2610-2615
44. Leong KG, Wang BE, Johnson L, Gao WQ (2008) Generation of a prostate from a single cell. Nature 456:804-808
45. Liu AY, True L (2002) Characterization of prostate cell types by CD cell surface molecules. Am J Pathol 160:37-43
46. Liu AY, Roudier MP, True LD (2004) Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile. Am J Pathol 165:1543-1556
47. Liu J, Pascal LE, Isharwal S, Metzger D, Ramos Garcia R, Pilch J, Kasper S, Williams K, Basse PH, Nelson JB et al (2011) Regenerated luminal epithelial cells are derived from preexisting luminal epithelial cells in adult mouse prostate. Mol Endocrinol 25:1849-1857
48. Long RM, Morrissey C, Fitzpatrick JM, Watson RW (2005) Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapies. Clin Sci (Lond) 108:1-11
49. Lowsley OS (1912) The development of the human prostate gland with reference to the development of other structures at the neck of the urinary bladder. Am J Anat 13:299-348
50. Lukacs RU, Goldstein AS, Lawson DA, Cheng D, Witte ON (2010) Isolation, cultivation and characterization of adult murine prostate stem cells. Nat Protoc 5:702-713
51. Maitland NJ, Collins AT (2008) Prostate cancer stem cells: a new target for therapy. J Clin Oncol 26:2862-2870
52. Maitland NJ, Frame FM, Polson ES, Lewis JL, Collins AT (2011) Prostate cancer stem cells: do they have a basal or luminal phenotype? Horm Cancer 2:47-61
53. Mathew G, Timm EA Jr, Sotomayor P, Godoy A, Montecinos VP, Smith GJ, Huss WJ (2009) ABCG2-mediated DyeCycle Violet effl ux defined side population in benign and malignant prostate. Cell Cycle 8:1053-1061
54. Maund SL, Barclay WW, Hover LD, Axanova LS, Sui G, Hipp JD, Fleet JC, Thorburn A, Cramer SD (2011) Interleukin-1alpha mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells. Cancer Res 71:5276-5286
55. McCormick DL, Rao KVN, Steele VE, Lubet RA, Kelloff GJ, Bosland MC (1999) Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid. Canc Res 59:521-524
56. McNeal JE (1983) The prostate gland: morphology and pathobiology. Monogr Urol 4:3-11
57. McPherson SJ, Hussain S, Balanathan P, Hedwards SL, Niranjan B, Grant M, Chandrasiri UP, Toivanen R, Wang Y, Taylor RA et al (2010) Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated. Proc Natl Acad Sci USA 107:3123-3128
58. Metallo CM, Ji L, de Pablo JJ, Palecek SP (2008) Retinoic acid and bone morphogenetic protein signaling synergize to efficiently direct epithelial differentiation of human embryonic stem cells. Stem Cells 26:372-380
59. Miki J, Rhim J (2008) Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells. Prostate Cancer Prostatic Dis 11:32-39
60. Moore KL, Persaud TVN (2008) Before we are born, essentials of embryology and birth defects, 7th edn. Saunders/Elsevier, Philadelphia
61. Morrison SJ, Kimble J (2006) Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 441:1068-1074
62. Oldridge EE, Pellacani D, Collins AT, Maitland NJ (2012) Prostate cancer stem cells: are they androgen-responsive? Mol Cell Endocrinol 360(1-2):14-24
63. Presnell SC, Petersen B, Heidaran M (2002) Stem cells in adult tissues. Semin Cell Dev Biol 13:369-376
64. Prins GS (1993) Development of the prostate. In: Reproductive issues and the aging male (Eds. F. Haseltine, A. Paulsen, C. Wang), pp 101-112. Embryonic, Inc, New York
65. Prins GS, Birch L (1995) The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen. Endocrinology 136:1303-1314
66. Prins GS, Korach KS (2008) The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73:233-244
67. Prins GS, Putz O (2008) Molecular signaling pathways that regulate prostate gland development. Differentiation 6:641-659
68. Prins GS, Cooke PS, Birch L, Donjacour AA, Yalcinkaya TM, Siiteri PK, Cunha GR (1992) Androgen receptor expression and 5a-reductase activity along the proximal-distal axis of the rat prostatic duct. Endocrinology 130:3066-3073
69. Prins GS, Birch L, Woodham C (1995) Effect of neonatal estrogen on androgen receptor protein and mRNA levels in developing rat ventral prostate. Paper presented at: 77th annual meeting of the endocrine society, Washington, DC
70. Rajasekhar VK, Studer L, Gerald W, Socci ND, Scher HI (2011) Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-kappaB signalling. Nat Commun 2:162
71. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, Collins AT (2003) CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117:3539-3545
72. Ricke WA, McPherson SJ, Bianco JJ, Cunha GR, Wang Y, Risbridger GP (2008) Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling. FASEB J 22:1512-1520
73. Robinson EJ, Neal DE, Collins AT (1998) Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate 37:149-160
74. Rouet V, Bogorad RL, Kayser C, Kessal K, Genestie C, Bardier A, Grattan DR, Kelder B, Kopchick JJ, Kelly PA et al (2010) Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors. Proc Natl Acad Sci USA 107:15199-15204
75. Rumpold H, Heinrich E, Untergasser G, Hermann M, Pfister G, Plas E, Berger P (2002) Neuroendocrine differentiation of human prostatic primary epithelial cells in vitro. Prostate 53:101-108
76. Scaffidi P, Misteli T (2011) In vitro generation of human cells with cancer stem cell properties. Nat Cell Biol 13:1051-1061
77. Schalken JA (2007) Prostate cancer stem cells. In: Prostate cancer: biology, genetics and the new therapeutics (Eds. L. Chung, W. Isaacs, J. Simons), pp 63-72, 2nd edn. Humana, Totowa
78. Schenk JM, Riboli E, Chatterjee N, Leitzmann MF, Ahn J, Albanes D, Reding DJ, Wang Y, Friesen MD, Hayes RB et al (2009) Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 18:1227-1231
79. SharifiN, Hurt EM, Farrar WL (2008) Androgen receptor expression in prostate cancer stem cells: is there a conundrum? Cancer Chemother Pharmacol 62:921-923
80. Sissung TM, Danesi R, Kirkland CT, Baum CE, Ockers SB, Stein EV, Venzon D, Price DK, Fig. WD (2011) Estrogen receptor a and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxelbased therapy. J Clin Endocrinol Metab 95:E368-E372
81. Smith S, Neaves W, Teitelbaum S (2007) Adult versus embryonic stem cells: treatments. Science 316:1422-1423
82. Timms BG, Mohs TJ, Didio LJ (1994) Ductal budding and branching patterns in the developing prostate. J Urol 151:1427-1432
83. Tomasetti C, Levy D (2010) Role of symmetric and asymmetric division of stem cells in developing drug resistance. Proc Natl Acad Sci USA 107:16766-16771
84. Tsujimura A, Koikawa Y, Salm S, Takao T, Coetzee S, Moscatelli D, Shapiro E, Lepor H, Sun TT, Wilson EL (2002) Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J Cell Biol 157:1257-1265
85. Vander Griend DJ, Karthaus WL, Dalrymple S, Meeker A, DeMarzo AM, Isaacs JT (2008) The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res 68:9703-9711
86. Vander Griend DJ, D'Antonio J, Gurel B, Antony L, Demarzo AM, Isaacs JT (2010) Cellautonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells. Prostate 70:90-99
87. Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I (2002) Estradiol in elderly men. Aging Male 5:98-102
88. Vezina CM, Lin TM, Peterson RE (2009) AHR signaling in prostate growth, morphogenesis, and disease. Biochem Pharmacol 77:566-576
89. Wang ZA, Shen MM (2011) Revisiting the concept of cancer stem cells in prostate cancer. Oncogene 30:1261-1271
90. Wang Y, Hayward S, Cao M, Thayer K, Cunha G (2001a) Cell differentiation lineage in the prostate. Differentiation 68:270-279
91. Wang Y, Chang WY, Prins GS, van Breeman RB (2001b) Simultaneous determination of all-trans, 9-cis, 13-cis retinoic acid and retinal in rat prostate using liquid. J Mass Spectrom 36:882-888
92. Wang Z, Prins GS, Coschigano KT, Kopchick JJ, Green JE, Ray VH, Hedayat S, Christov KT, Unterman TG, Swanson SM (2005) Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse. Endocrinology 146:5188-5196
93. Wang G, Wang Z, Sarkar FH, Wei W (2012) Targeting prostate cancer stem cells for cancer therapy. Discov Med 13:135-142
94. Wu M, Kwon HY, Rattis F, Blum J, Zhao C, Ashkenazi R, Jackson TL, Gaiano N, Oliver T, Reya T (2007) Imaging hematopoietic precursor division in real time. Cell Stem Cell 1:541-554
95. Xin L, Lawson DA, Witte ON (2005) The Sca-1 cell surface marker enriches for a prostateregenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci USA 102:6942-6947
96. Xin L, Lukacs RU, Lawson DA, Cheng D, Witte ON (2007) Self-renewal and multilineage differentiation in vitro from murine prostate stem cells. Stem Cells 25:2760-2769
97. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H et al (2001) The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7:1028-1034